Singapore · Venture startup

Who invested in KYAN Therapeutics

One round we have observed, with the one investor named in it. Every figure came from a named source, and where the company reported a raise to the SEC itself, that is shown beside it.

AI

Funding summaryUpdated 26 Oct 2026

Undisclosedraised across 1 round since 2024, from 1 source

Latest round
VentureMay 2024
Investors
1
See who backed them

The rounds

  1. May 2024
    VentureAmount undisclosed

    Source recorded

Founders and team

From KYAN Therapeutics's own website: 3 founders, 6 on the team.

Hugo SaavedraCEO & Co-founder
Lisa ChowChief Legal Officer & Co-founder
Edward ChowCSO & Co-founder
  • Boon Yan TengFinance Manager
  • Jhin Jieh LimResearch Scientist
  • Michael ChingLab Manager
  • Stephanie ToCommercial Director
  • Sudha SruthiCorporate Development Manager
  • Weng Tong HoMedical Affairs Director

Everyone who backed them

Seeds CapitalVC firm1round

Missing a round, or an investor who was in one? Tell us.

Quick answers about KYAN Therapeutics

Who invested in KYAN Therapeutics?

KYAN Therapeutics's investors include Seeds Capital.

How much has KYAN Therapeutics raised?

KYAN Therapeutics has raised 1 round since 2024, none with a disclosed amount.

When did KYAN Therapeutics last raise?

KYAN Therapeutics's most recent round was a Venture in May 2024.

Who backed KYAN Therapeutics first?

KYAN Therapeutics's first round on record, in May 2024, was backed by Seeds Capital.

What stage is KYAN Therapeutics at?

KYAN Therapeutics's latest named round is a Venture, in May 2024.

Where is KYAN Therapeutics based?

KYAN Therapeutics is based in Singapore.

Companies like KYAN Therapeutics

In the same sector, and raised in the last eighteen months.

Find investors like these

Search every investor by what they have actually funded, then narrow to your stage and market. Free.